BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 14983488)

  • 1. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
    Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
    Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy type does not influence sentinel lymph node status.
    Chagpar AB; Scoggins CR; Sahoo S; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
    Am J Surg; 2005 Oct; 190(4):551-6. PubMed ID: 16164918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.